Literature DB >> 8843230

Human immunodeficiency virus in plasma and genital secretions during the menstrual cycle.

C Goulston1, E Stevens, D Gallo, J I Mullins, C V Hanson, D Katzenstein.   

Abstract

Six human immunodeficiency virus (HIV)-positive women were studied weekly over 8 weeks to detect HIV RNA in plasma and cervical secretions and proviral DNA in cervical, vaginal, and cervicovaginal lavage samples by polymerase chain reaction (PCR) amplification techniques. In cervical swab samples, cell-free HIV RNA was detected more frequently than cell-associated HIV proviral DNA (22/48 vs. 7/48, respectively). Cervical HIV RNA was consistently detected in 2 women with plasma HIV RNA > 100,000 copies/mL but was not detected in 2 women with plasma HIV RNA < 10,000 copies/mL, regardless of menstruation status. HIV-specific IgA was detected in the plasma of 2 women and in at least 1 cervicovaginal lavage sample from all 6 women. Thus, quantitation of cervical HIV RNA can be accomplished by PCR techniques and may be useful in evaluation genital viral shedding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843230     DOI: 10.1093/infdis/174.4.858

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge.

Authors:  Sarah Benki; Sara B Mostad; Barbra A Richardson; Kishorchandra Mandaliya; Joan K Kreiss; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

Review 2.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

3.  Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination.

Authors:  Sean Philpott; Harold Burger; Christos Tsoukas; Brian Foley; Kathryn Anastos; Christina Kitchen; Barbara Weiser
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.

Authors:  Athena P Kourtis; Lisa Haddad; Jennifer Tang; Lameck Chinula; Stacey Hurst; Jeffrey Wiener; Sascha Ellington; Julie A E Nelson; Amanda Corbett; Kristina De Paris; Caroline C King; Mina Hosseinipour; Irving F Hoffman; Denise J Jamieson
Journal:  Contemp Clin Trials       Date:  2016-11-09       Impact factor: 2.226

5.  Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes.

Authors:  C H Contag; A Ehrnst; J Duda; A B Bohlin; S Lindgren; G H Learn; J I Mullins
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.

Authors:  Anandi N Sheth; Tammy Evans-Strickfaden; Richard Haaland; Amy Martin; Chelsea Gatcliffe; Adebola Adesoye; Michael W Omondi; L Davis Lupo; Damien Danavall; Kirk Easley; Cheng-Yen Chen; Chou-Pong Pau; Clyde Hart; Igho Ofotokun
Journal:  J Infect Dis       Date:  2014-03-18       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.